Status:
COMPLETED
Symptomatic Treatment Of Patients With Neuropathic Pain With LYRICA
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Neuropathic Pain
Eligibility:
All Genders
18+ years
Brief Summary
A Non-Interventional, Post-Marketing Surveillance (NI-PMS) study whose objectives were to assess the impact of pregabalin on subjects' pain, quality of sleep, and their general wellbeing, as well as t...
Detailed Description
A non-interventional study of patients diagnosed with neuropathic pain administered pregabalin and followed up for 8 weeks
Eligibility Criteria
Inclusion
- Clinical diagnosis of neuropathic pain and inclusion according to the current Summary of Product Characteristics.
Exclusion
- The patients were excluded according to the current Summary of Product Characteristics.
Key Trial Info
Start Date :
September 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
691 Patients enrolled
Trial Details
Trial ID
NCT00843284
Start Date
September 1 2006
End Date
March 1 2008
Last Update
February 10 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.